QUALITY BY DESIGN-BASED REVERSE PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY METHOD DEVELOPMENT AND VALIDATION FOR FINERENONE IN TABLET DOSAGE FORM Authors: Sakhare RS , BHATANE RB, MALWAD VB, MARSHIVANE PH, ZINGADE SG
ABSTRACT
The objective of this study is to develop Simple, rapid, and sensitive RP-HPLC for Finerenone in tablet
dosage form by QbD approach. In this method, Finerenone was estimated using C18 Sunfire column
(250×4.6 mm, 4.8 ?m) and 0.01N KH2:PO4: methanol (61.2:38.8 % V/V) as mobile phase and flow rate
1 mL/min which are optimized using Design-Expert software. Method was developed at 272 nm
detection wavelength. The retention time was found to be 3.051min. The proposed method was
successfully applied to the determination of Finerenone in tablet dosage form. High linearity of
developed method was confirmed over concentration range of (5-30) ?g/mL and correlation co-efficient
is 0.9994. The recovery was found to be 100.68 %; LOD was found to be 0.31 ?g/mLand LOQ was
found to be 0.95 ?g/mL. There was no interference of excipient and degradation product in retention
time, so the method was specific. Analytical parameters such as precision, accuracy, LOD, LOQ and
robustness were determined according to ICH guidelines.
Keywords: Finerenone, QbD Approach, Method development, RP-HPLC, LOD, LOQ Publication date: 01/09/2026 https://www.ijbpas.com/pdf/2026/September/MS_IJBPAS_2026_10457.pdfDownload PDFhttps://doi.org/10.31032/IJBPAS/2026/15.9.10457